Advertisement
Advertisement
U.S. markets open in 3 hours 23 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Tissue Repair Ltd (TRP.AX)

ASX - ASX Delayed Price. Currency in AUD
0.2200-0.0100 (-4.35%)
At close: 03:58PM AEDT
Advertisement

Tissue Repair Ltd

255 Pitt Street
Level 10
Sydney, NSW 2000
Australia
61 4 1955 7663
https://www.tissuerepair.com.au

Sector(s)Healthcare
IndustryBiotechnology
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Mr. Tony ChararaCo-Founder & Exec. Director80.97kN/AN/A
Mr. Cameron Jones C.A.Chief Financial OfficerN/AN/AN/A
Dr. Darryl ReedChief Operating OfficerN/AN/AN/A
Mr. Michael AustinCompany Sec.N/AN/AN/A
Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.

Description

Tissue Repair Ltd, a clinical stage biopharmaceutical company, developing advanced wound healing products for chronic wounds and the aftercare of cosmetic procedures in Australia. It is developing TR-987 and other dressing/matrices, including Glucoprime technology for the treatment of chronic wounds, burns, and other complex wounds; and TR Pro+ for aftercare of minimally invasive cosmetic procedures, as well as other products for veterinary, new bandage, scaffold products, and other therapeutic indications. The company was incorporated in 2012 and is headquartered in Sydney, Australia.

Corporate Governance

Tissue Repair Ltd’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Advertisement
Advertisement